| Date | Actual event | Procurement implication |
|---|---|---|
| November 27, 2026 | Staffing measurement date for the new small-dispenser exemption | Record corporate-level eligibility; do not confuse it with the extended exemption’s end date. (fda.gov) |
| December 31, 2026 | End of FDA’s FY2027 outsourcing-facility registration window; FY2026 registrations expire | Obtain updated registration evidence for any relevant 503B partner. Registration remains separate from product eligibility. (fda.gov) |
| January 1, 2027 | Last state-entry date currently stated for Medicaid BALANCE | Verify target-state participation and implementation; this is not a clinic enrolment deadline. (cms.gov) |
| November 27, 2027 | Stated end of the specified small-dispenser DSCSA exemptions | Maintain an implementation plan rather than postponing all traceability work. (fda.gov) |
| December 31, 2027 | Current scheduled end of Medicare GLP-1 Bridge | Include coverage-transition monitoring in partner responsibilities. (cms.gov) |
Explore the table row by row
A working view of the research
November 27, 2026
- Actual event
- Staffing measurement date for the new small-dispenser exemption
- Procurement implication
- Record corporate-level eligibility; do not confuse it with the extended exemption’s end date. (fda.gov)
Sources cited on this page
- fda.gov · Source 1 ↗https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/exemptions-under-drug-supply-chain-security-act
- fda.gov · Source 2 ↗https://www.fda.gov/industry/fda-user-fee-programs/human-drug-compounding-outsourcing-facility-fees?utm_source=openai
- cms.gov · Source 3 ↗https://www.cms.gov/priorities/innovation/innovation-models/balance
- cms.gov · Source 4 ↗https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf